Repeated graft loss caused by recurrent hepatic artery thrombosis after liver transplantation

Hepatic artery thrombosis (HAT) is a main cause of graft loss and patient mortality after orthotopic liver transplantation (OLT). Several surgical and nonsurgical risk factors have been associated with HAT. Retransplantation often is the only possible treatment for this complication; however, the incidence of recurrence of HAT after retransplantation and the underlying conditions of this occurrence have never been investigated. Of 629 consecutive recipients transplanted at a single institution, 24 underwent retransplantion for HAT: in 4 of them (16%), HAT recurred in the second graft; 3 of these patients lost their first graft because of late HAT, whereas another one lost 4 consecutive grafts for early HAT. Antiphospholipid syndrome and paroxysmal nocturnal hemoglobinuria were diagnosed in three and one of these patients, respectively. Recurrent HAT is an uncommon occurrence that, in our experience, was linked to specific thrombophilic conditions; careful screening of these disorders should be included in the pretransplant workup, and adequate prophylaxis is advisable.

[1]  J. Neuberger,et al.  Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-a 12-year experience. , 2001, Transplantation.

[2]  A. Burroughs,et al.  Hepatic artery thrombosis after orthotopic liver transplantation: A review of nonsurgical causes , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  M. Colombo,et al.  Nonpercutaneous therapies of hepatocellular carcinoma. , 2001, Hepato-gastroenterology.

[4]  P. Kimball,et al.  Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study. , 2000, Transplantation.

[5]  S. Schuetze,et al.  Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. , 1999, Transplantation.

[6]  B. Rudolph,et al.  Recurrence of the Budd-Chiari syndrome after orthotopic liver transplantation. , 1999, Hepato-gastroenterology.

[7]  G. Alexander,et al.  Graft loss and the antiphospholipid syndrome following liver transplantation. , 1998, Journal of hepatology.

[8]  Stephen M. Johnson,et al.  Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation. , 1997, Transplantation.

[9]  K. Olthoff,et al.  Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT). , 1996, The American surgeon.

[10]  G. Falk,et al.  Anticardiolipin antibody-associated cerebral infarction in cirrhosis: clearance of anticardiolipin antibody after liver transplantation. , 1994, The American journal of gastroenterology.

[11]  S. Basili,et al.  Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels. , 1994, Journal of hepatology.

[12]  M. L. de la Mata,et al.  Diminished anticoagulant and fibrinolytic activity following liver transplantation. , 1992, Transplantation.

[13]  R. Stratta,et al.  Vascular complications after orthotopic liver transplantation. , 1991, American journal of surgery.

[14]  W. Millikan,et al.  A hypercoagulable state follows orthotopic liver transplantation , 1990, Hepatology.

[15]  T. Starzl,et al.  CLINICAL PRESENTATION OF HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION IN THE CYCLOSPORINE ERA , 1985, Transplantation.